Escolar Documentos
Profissional Documentos
Cultura Documentos
CROSLINKED
S -L I NKEDHYALALURONIC
HYAL
HY A CID++L ID
U R O NIC ACID LIDOCAINE
O CAINE
Portfolio Cover
(stripes to show through die-cut cover)
A new generation of dermal fillers
Emervel is a new range of hyaluronic acid fillers from Galderma
Emervel uses Optimal Balance TechnologyTM to achieve the perfect gel texture
for integration into the various layers or areas of the skin
All variants contain lidocaine 3mg/ml to maximise patient comfort and prevent stinging*
No free HA needed
*Emervel Touch with lidocaine will be available later in 2011.
Emervel Touch without lidocaine is available now.
Gel texture
Level of cross-linking
Level of calibration
Viscosity Soft, subtle
Before
Pack 1 x 1ml
After
Gel texture
Level of cross-linking
Level of calibration
Viscosity Intermediate firmness
Before
Pack 1 x 1ml
After
Gel texture
Level of cross-linking
Level of calibration
Viscosity Firm
Before
Pack 1 x 1ml
After
Gel texture
Level of cross-linking
Level of calibration
Viscosity High firmness
Before
Photos: Dr B. Ascher
Suggested injection depth Subcutaneous
Pack 1 x 2ml
After
Gel texture
Level of cross-linking
Level of calibration
Viscosity Firm
Before
Photos: Dr D. Farhi
Suggested injection depth Subcutaneous
Pack 1 x 2ml
After
Photos: Dr B. Ascher
Before After
Photos: Dr P. Kestemont
Before After
www.emervel.co.uk
For further information please contact the Procedure Team at Galderma (UK) Limited,
Meridien House, 69-71 Clarendon Road, Watford, Herts, WD17 1DS.
Tel: +44 (0)1923 208950 Fax: +44 (0)1923 208998.
Emervel is a medical device. Injectable solution for aesthetic use. Emervel is a trademark
owned by Galderma S.A. Emervel CE 0459. Copyright 2011 Galderma (UK) Ltd.